Cite
Methylprednisolone for the Treatment of Patients with Acute Spinal Cord Injuries: A Propensity Score-Matched Cohort Study from a Canadian Multi-Center Spinal Cord Injury Registry.
MLA
Evaniew, Nathan, et al. “Methylprednisolone for the Treatment of Patients with Acute Spinal Cord Injuries: A Propensity Score-Matched Cohort Study from a Canadian Multi-Center Spinal Cord Injury Registry.” Journal of Neurotrauma, vol. 32, no. 21, Nov. 2015, pp. 1674–83. EBSCOhost, https://doi.org/10.1089/neu.2015.3963.
APA
Evaniew, N., Noonan, V. K., Fallah, N., Kwon, B. K., Rivers, C. S., Ahn, H., Bailey, C. S., Christie, S. D., Fourney, D. R., Hurlbert, R. J., Linassi, A. G., Fehlings, M. G., & Dvorak, M. F. (2015). Methylprednisolone for the Treatment of Patients with Acute Spinal Cord Injuries: A Propensity Score-Matched Cohort Study from a Canadian Multi-Center Spinal Cord Injury Registry. Journal of Neurotrauma, 32(21), 1674–1683. https://doi.org/10.1089/neu.2015.3963
Chicago
Evaniew, Nathan, Vanessa K Noonan, Nader Fallah, Brian K Kwon, Carly S Rivers, Henry Ahn, Christopher S Bailey, et al. 2015. “Methylprednisolone for the Treatment of Patients with Acute Spinal Cord Injuries: A Propensity Score-Matched Cohort Study from a Canadian Multi-Center Spinal Cord Injury Registry.” Journal of Neurotrauma 32 (21): 1674–83. doi:10.1089/neu.2015.3963.